ArticleJournal of clinical practice and research2025
Brucellosis Seroprevalence and Diagnostic Challenges: A Comprehensive Review from 2017-2021.
Article in Journal of clinical practice and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bacterial Infection in Ebola Virus Disease, Marburg Virus Disease, Crimean-Congo Hemorrhagic Fever, and Lassa Fever.Open forum infectious diseases · 2026Review
- Ultrasensitive Detection and Its Potential Applications in the Diagnosis of Brucellosis.Current microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the performance of the Rose Bengal test (RB), serum agglutination test (SAT), and Coombs test (CT) in samples suspected of brucellosis, analyze the seasonal distribution, examine the relationship with Crimean-Congo hemorrhagic fever (CCHF), which is frequently observed in our region, and determine the seroprevalence of brucellosis in the area. Materials and Methods: A retrospective analysis was conducted on 12,279 brucellosis-suspected samples submitted from various clinics between 2017 and 2021. RB, SAT, and CT tests were performed, and results were analyzed concerning seasonal and yearly distributions as well as factors such as age and gender differences. Results: Among the 12,279 RB tests conducted, 281 (2.3%) were positive, and 11,998 (97.7%) were negative. Of the positive results, 96 samples were positive for both RB and SAT, while 185 were RB positive but SAT negative. CT provided positive results in 101 out of 185 cases with discordant RB and SAT results. The seroprevalence rate was 1.5%, with higher rates observed among males and during the spring and summer seasons. A notable increase in seropositivity was observed during the pandemic. Conclusion: This study highlights the annual and seasonal distribution of brucellosis and differences across age and gender groups. The Coombs test played a crucial role in resolving cases with discordant RB and SAT results. A rise in brucellosis cases during the pandemic was noted, with significant co-infections involving CCHF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.